One Pathway for Esophageal Cancer? - Takeaways - MDSpire
From the Journals

One Pathway for Esophageal Cancer?

Molecular profiling reveals precursor signals in BE-negative esophageal cancer

  • May 7, 2026

  • 2 min

Share

  • 1

    EAC can arise without detectable Barrett's Esophagus (BE).

  • 2

    Study included 3,100 patients across 25 UK centers.

  • 3

    Similar demographic profiles for patients with and without BE were observed.

  • 4

    Key mutations like CDKN2A and TP53 present in both EAC types.

  • 5

    TFF3 and REG4 markers also detected in tumors lacking identifiable BE.

  • 6

    Tumor stage differences noted, with BE-negative EAC at advanced stages.

  • 7

    Findings suggest common precursor biology in EAC regardless of BE visibility.

Original Source(s)

One Pathway for Esophageal Cancer?

  • May 7, 2026

Related Content

Plasma miR-371a-3p Predicts Recurrence in Stage I Testicular Cancer: Interim Results From the CLIMATE Study

In the management of stage I testicular cancer, a persistent clinical dilemma is the identification of patients who truly need adjuvant treatment after orchiectomy rather than active surveillance alon...

‘Promising’ Signal Only: ctDNA in Early Breast Cancer Not Yet Ready for Clinical Use

Despite compelling prognostic associations across multiple retrospective data sets, no interventional trial has demonstrated that acting on circulating tumor DNA testing results in early breast cancer...

Experimental Daraxonrasib Shows Promise in Advanced Pancreatic Cancer

Metastatic pancreatic ductal adenocarcinoma remains one of the most challenging malignancies to treat in clinical oncology.

  • by

  • May 6, 2026

  • 5 min